Company Overview and News

1
Here's Why You Should Hold Grubhub Stock in Your Portfolio

2018-09-20 zacks
Grubhub (GRUB - Free Report) earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters, delivering an average positive earnings surprise of 25.6%. With expected long-term earnings per share growth rate of 25% and a market cap of $12.99 billion, it seems to be a stock that investors should keep in their portfolio for now. Let’s take a look at the factors that have been driving the company’s performance.
GRPN YUM YELP GRUB

11
Tencent-backed Meituan climbs 5 percent on debut, brightens outlook for HK IPOs

2018-09-20 channelnewsasia
Meituan Dianping climbed on debut in Hong Kong on Thursday, valuing the Chinese online food delivery-to-ticketing services firm at about US$55 billion and sending a positive signal to companies lining up to list in the financial hub.
BABA GRPN YELP 0700 TRI

11
UPDATE 4-Tencent-backed Meituan climbs 5 pct on debut, brightens outlook for HK IPOs

2018-09-20 reuters
HONG KONG (Reuters) - Meituan Dianping (3690.HK) rose 5 percent on debut in Hong Kong on Thursday, valuing the Chinese online food delivery-to-ticketing services firm at about $55 billion and sending a positive signal to companies lining up to list in the financial hub.
BABA GRPN YELP 0700

11
Tencent-backed Meituan jumps 5 percent on debut, brightens outlook for HK IPOs

2018-09-20 channelnewsasia
Meituan Dianping climbed on debut in Hong Kong on Thursday, valuing the Chinese online food delivery-to-ticketing services firm at about US$55 billion and sending a positive signal to companies lining up to list in the financial hub.
GRPN BABA YELP 0700 TRI MS

11
UPDATE 3-Tencent-backed Meituan jumps 5 pct on debut, brightens outlook for HK IPOs

2018-09-20 reuters
HONG KONG (Reuters) - Meituan Dianping (3690.HK) climbed on debut in Hong Kong on Thursday, valuing the Chinese online food delivery-to-ticketing services firm at about $55 billion and sending a positive signal to companies lining up to list in the financial hub.
GRPN BABA YELP 0700 MS

65
Alibaba Vs. All: This Would Be Ugly

2018-09-18 seekingalpha
The retail sector is turning into a battle between three main players: Alibaba, Amazon, and Walmart/Tencent.
JD GRPN KR AMZN JPM GOOGL KSS MSFT BBY WMT

1
Grubhub Completes LevelUp Buyout, Set to Buy OrderUp Assets

2018-09-14 zacks
Grubhub (GRUB - Free Report) recently completed the acquisition of LevelUp, which manages digital ordering and payment solutions for national and regional restaurants, for $390 million in cash. LevelUp has a customer base comprising the likes of Roti, Pret a Manger, Zaxby's and Just Salad, among others. The acquisition will add more than 200 customers with robust point-of-sale integrations. Grubhub expects the LevelUp transaction to contribute revenues of approximately $2 million to third-quarter results.
GRPN YUM CY YELP GRUB

1
The Wall Street Journal: Chinese app Meituan, backed by Tencent, raises $4.2 billion in IPO

2018-09-13 marketwatch
Chinese startup Meituan Dianping raised about $4.2 billion from its initial public offering in Hong Kong, according to people familiar with the situation, defying a weak market to show investors remain keen on fast-growing technology companies.
GRPN GRUB YELP 0700

11
Tencent-backed Meituan raises US$4.2 billion in IPO priced near top of range: Sources

2018-09-13 channelnewsasia
HONG KONG: Chinese online food delivery-to-ticketing services firm Meituan Dianping raised US$4.2 billion in the world's biggest internet-focused IPO in four years as it priced the float near the top of an indicative range, people close to the deal said.
GRPN BABA YELP 0700 MS

11
UPDATE 3-Tencent-backed Meituan raises $4.2 bln in IPO priced near range top-sources

2018-09-13 reuters
HONG KONG (Reuters/IFR) - Chinese online food delivery-to-ticketing services firm Meituan Dianping raised $4.2 billion in the world’s biggest internet-focused IPO in four years as it priced the float near the top end of a marketed range, people close to the deal said.
MLHK YELP SFTBF GRPN BABA 0700 9984 MS SFTBY

11
Tencent-backed Meituan raises US$4.2 billion in IPO priced near top of range: sources

2018-09-13 channelnewsasia
Chinese online food delivery-to-ticketing services firm Meituan Dianping raised US$4.2 billion in the world's biggest internet-focused IPO in four years as it priced the float near the top of an indicative range, people close to the deal said.
GRPN BABA YELP 0700 MS

61
JD.com Has Tremendous Potential And Its CEO Will Recover

2018-09-04 investorplace
Taking classes is apparently more popular among the CEOs of Chinese companies than among their American counterparts. We learned last week that JD.com (NASDAQ:JD) CEO Richard Liu was enrolled in a business doctorate program run by Beijing’s Tsinghua University and, surprisingly, the University of Minnesota. Thus, Liu was in Minneapolis last week when something happened. Maybe it was a misunderstanding, maybe it was something more.
JD GRPN BABA UL AMZN TCEHY GOOGL FDX TCTZF WMT

9
4 Small-Cap Stocks That Are In Serious Trouble

2018-08-31 investorplace
U.S. equities moved lower on Thursday — the first decline in five sessions — as optimism around trade talks with Canada are eclipsed by a worsening situation in emerging market currencies. Argentina raised its policy rate by 15% to 60% to try to bolster its falling currency. There are bloodbaths underway in Brazil’s and Turkey’s currencies as well.
MIK GRPN LC GME

36
Groupon (GRPN) Expands Alliance with MLBAM's Tickets.com

2018-08-31 zacks
Groupon, Inc. (GRPN - Free Report) recently entered into an extended strategic relationship with MLBAM’s privately owned subsidiary, Tickets.com. Per the partnership, Groupon will be able to furnish robust ticketing experiences to major ticketing clients of Tickets.com. Tickets.com’s Registered Developer Program enables validated third-party offerings to integrate with its ProVenue ticketing platform.
GRPN AMZN GRUB RSG

75
Alibaba Reveals Bigger Threats Than Trade War

2018-08-30 seekingalpha - 3
In the next few quarters, Alibaba will have to tackle a number of threats which can hinder its future growth potential.
JD BABA PDD GRPN AMZN MSFT GOOG WMT SNAP

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to GRPN / Groupon, Inc. on message board site Silicon Investor.

Groupon, Inc. Groupon, Inc. Groupon, Inc. MYRY GRPN Killer? MYRY GRPN Killer? MYRY GRPN Killer?
CUSIP: 399473107